Doxazosin. a postsynaptic alpha 1-adrenergic receptor blocker in therapy of hypertension
Dominiak, P.
Der Internist 34(7): 682-687
1993
ISSN/ISBN: 0020-9554 PMID: 8103510 Document Number: 416174
Document emailed within 1 workday
Related Documents
Lewczuk, J.; Piszko, P.; Jagas, J.; Wrabec, K. 2005: Impact of 30 day therapy with doxazosin--alpha1 adrenergic blocker on pulmonary hemodynamics in patients with secondary pulmonary hypertension due to chronic obstructive pulmonary disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(105): 279-281Renouard, A.; Widdowson, P.S.; Millan, M.J. 1994: Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes Journal of Pharmacology and Experimental Therapeutics 270(3): 946-957
Wang, J.; Li, J.; Lu, R.; Wang, J.-M. 2002: Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis Zhonghua Nan Ke Xue 8(1): 48-50
Price, D.T.; Chari, R.S.; Berkowitz, D.E.; Meyers, W.C.; Schwinn, D.A. 1994: Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification Molecular Pharmacology 46(2): 221-226
De Champlain, J. 1990: Pre- and postsynaptic adrenergic dysfunctions in hypertension Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 8(7): S77-S85
Zonis, B.Ia.; Brin, V.B. 1979: Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane Terapevticheskii Arkhiv 51(11): 28-30
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
Eiam-Ong, S.; Eiam-Ong, S.; Punsin, P.; Sitprija, V.; Chaiyabutr, N. 2004: Acute hypercalcemia-induced hypertension: the roles of calcium channel and alpha-1 adrenergic receptor Journal of the Medical Association of Thailand 87(4): 410-418
Bylund, D.B.; Ray-Prenger, C. 1989: Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype Journal of Pharmacology and Experimental Therapeutics 251(2): 640-644
Lorenz, W.; Lomasney, J.W.; Collins, S.; Regan, J.W.; Caron, M.G.; Lefkowitz, R.J. 1990: Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification Molecular Pharmacology 38(5): 599-603
Price, D.T.; Lefkowitz, R.J.; Caron, M.G.; Berkowitz, D.; Schwinn, D.A. 1994: Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology Molecular Pharmacology 45(2): 171-175
Nakaki, T.; Nakadate, T.; Ishii, K.; Kato, R. 1981: Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation Journal of Pharmacology and Experimental Therapeutics 216(3): 607-612
Fracasso, J.F.; Rothschild, A.M. 1983: Alpha and beta adrenergic blocker-resistant release of fibrinolytic activity from rat venae cavae by epinephrine in vitro Thrombosis and Haemostasis 49(1): 63
Laz, T.M.; Forray, C.; Smith, K.E.; Bard, J.A.; Vaysse, P.J.; Branchek, T.A.; Weinshank, R.L. 1994: The rat homologue of the bovine alpha 1c-adrenergic receptor shows the pharmacological properties of the classical alpha 1A subtype Molecular Pharmacology 46(3): 414-422
Heinz, N.; Hofferber, E. 1980: On the pharmacology of the alpha-receptor blocker BE 2254 (HEAT) Arzneimittel-Forschung 30(12): 2135-2139
Kawanishi, D.T.; Reid, C.L.; Gonzales, A.; O'Rourke, R.A.; Rahimtoola, S.H. 1989: Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina Circulation 80(6 Suppl): Iv162-Iv170
Shao, Y.; McCarthy, K.D. 1993: Quantitative relationship between alpha 1-adrenergic receptor density and the receptor-mediated calcium response in individual astroglial cells Molecular Pharmacology 44(2): 247-254
Forette, F.; Varin, D.; Henry, J.F.; Hervy, M.P. 1980: Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline La Nouvelle Presse Medicale 9(48): 3685-3688
Forette, F.; Henry, J.F.; Hervy, M.P.; Henry-Amar, M.; Brugier, S. 1983: Treatment of arterial hypertension in aged subjects with an alpha-blocker: prazosin Therapie 38(4): 387-392
Toya, Y.; Ebina, T.; Umemura, S. 2006: Alpha-Adrenergic receptor gene Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 5): 379-384